{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:47:45Z","timestamp":1790718465889,"version":"4.1.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Fibromyalgia (FM) is a chronic pain disorder characterized by widespread musculoskeletal pain, frequently accompanied by fatigue, sleep disturbances, cognitive dysfunction, and mood disorders. Although the etiology is multifactorial, involving genetic, hormonal, immunological, and environmental contributors, the exact pathophysiological mechanisms remain unclear, and the heterogeneity of symptoms poses significant challenges for diagnosis and management. Diagnostic criteria have evolved over the years, with newer approaches reducing some limitations, yet sex-related differences in clinical presentation continue to challenge timely and accurate diagnosis. Pharmacological therapy remains unsatisfactory: only pregabalin, duloxetine, and milnacipran have gained U.S. FDA approval, providing clinically meaningful relief in a minority of patients, and their frequent adverse events limit adherence. Numerous other agents, including cyclobenzaprine, gabapentinoids, NMDA antagonists, cannabinoids, and sodium oxybate, have been evaluated, but most remain investigational or limited by safety concerns. Current guidelines emphasize that pharmacological interventions alone are insufficient and should be integrated with non-pharmacological strategies, especially patient education, exercise, and psychological support. This review summarizes the evidence on available and emerging pharmacological options for FM, highlights their limitations, and underscores the need for individualized, multimodal treatment strategies to improve patient outcomes and quality of life.<\/jats:p>","DOI":"10.3389\/fphar.2025.1651181","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:18:27Z","timestamp":1760069907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacologic treatment of fibromyalgia: an update"],"prefix":"10.3389","volume":"16","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"B1","first-page":"742","article-title":"Guidelines for the diagnosis and treatment of the fibromyalgia syndrome","volume":"152","author":"Ablin","year":"2013","journal-title":"Harefuah"},{"key":"B2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/msc.1000","article-title":"\u03b11-Antitrypsin in fibromyalgia: results of a randomized, placebo-controlled, double-blind and crossover pilot trial","volume":"10","author":"Alegre","year":"2012","journal-title":"Musculoskelet. Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3390\/ijerph19095297","article-title":"Amigos de fibro (fibro friends): validation of an educational program to promote health in fibromyalgia","volume":"19","author":"Antunes","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s13063-023-07588-3","article-title":"A web-based educational therapy intervention associated with physical exercise to promote health in fibromyalgia in Brazil: the Amigos De Fibro (Fibro Friends) study protocol","volume":"24","author":"Antunes","year":"2023","journal-title":"Trials"},{"key":"B5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4081\/reumatismo.2021.1362","article-title":"The Italian society for rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia best practices based on current scientific evidence","volume":"73","author":"Ariani","year":"2021","journal-title":"Reumatismo"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3899\/jrheum.100365","article-title":"Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Arnold","year":"","journal-title":"J. Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.clinthera.2010.08.003","article-title":"Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"32","author":"Arnold","year":"","journal-title":"Clin. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/ar3359","article-title":"Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial","volume":"13","author":"Arnold","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/art.34390","article-title":"Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial","volume":"64","author":"Arnold","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/pme.12636","article-title":"Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia","volume":"16","author":"Arnold","year":"2015","journal-title":"Pain Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/03007995.2018.1450743","article-title":"An evidence-based review of pregabalin for the treatment of fibromyalgia","volume":"34","author":"Arnold","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1080\/03007995.2019.1629757","article-title":"Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study","volume":"35","author":"Arnold","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.2147\/JPR.S274562","article-title":"Efficacy and safety of ASP0819 in patients with fibromyalgia: results of a proof-of-concept, randomized, double-blind, placebo-controlled trial","volume":"13","author":"Arnold","year":"2020","journal-title":"J. Pain Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/jdi.13013","article-title":"Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase III study in Asian patients","volume":"10","author":"Baba","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/S0140-6736(21)01210-1","article-title":"Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial","volume":"398","author":"Banerjee","year":"2021","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/bja\/aet127","article-title":"Sex differences in pain: a brief review of clinical and experimental findings","volume":"111","author":"Bartley","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1097\/PR9.0000000000001080","article-title":"Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study","volume":"8","author":"Bested","year":"2023","journal-title":"Pain Rep."},{"key":"B20","first-page":"13","article-title":"Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo","volume":"18","author":"Biasi","year":"1998","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"B21","first-page":"2082","article-title":"Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency","volume":"31","author":"Blanco","year":"2004","journal-title":"J. Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.jpain.2021.04.011","article-title":"Substituting cannabidiol for opioids and pain medications among individuals with fibromyalgia: a large online survey","volume":"22","author":"Boehnke","year":"2021","journal-title":"J. Pain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40744-017-0088-9","article-title":"A blinded, randomized, placebo-controlled study to investigate the efficacy and safety of ferric carboxymaltose in iron-deficient patients with fibromyalgia","volume":"5","author":"Boomershine","year":"2018","journal-title":"Rheumatol. Ther."},{"key":"B24","first-page":"97","article-title":"Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia","volume":"85","author":"Cantini","year":"1994","journal-title":"Minerva Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/art.1780370106","article-title":"Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial","volume":"37","author":"Carette","year":"1994","journal-title":"Arthritis Rheum."},{"key":"B26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/AJP.0b013e31819be587","article-title":"A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia","volume":"25","author":"Chappell","year":"2009","journal-title":"Clin. J. Pain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/pm\/pnaa303","article-title":"Ingestion of a THC-Rich cannabis oil in people with fibromyalgia: a randomized, double-blind, placebo-controlled clinical trial","volume":"21","author":"Chaves","year":"2020","journal-title":"Pain Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3760\/cma.j.cn112138-20220602-00426","article-title":"Chinese recommendations for the management of fibromyalgia syndrome","volume":"62","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"CD008244","DOI":"10.1002\/14651858.CD008244.pub3","article-title":"Milnacipran for pain in fibromyalgia in adults","volume":"2015","author":"Cording","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","article-title":"Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies","volume":"4","author":"Del Giorno","year":"2015","journal-title":"Pain Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"CD011790","DOI":"10.1002\/14651858.CD011790.pub2","article-title":"Pregabalin for pain in fibromyalgia in adults","volume":"9","author":"Derry","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.psym.2010.12.014","article-title":"Psychological factors affecting response to antidepressant drugs in fibromyalgia","volume":"52","author":"D\u00edaz-Mars\u00e1","year":"2011","journal-title":"Psychosomatics"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/S2665-9913(23)00278-3","article-title":"Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial","volume":"6","author":"Due Bruun","year":"2024","journal-title":"Lancet Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0033-3182(98)71375-1","article-title":"An open clinical trial of venlafaxine treatment of fibromyalgia","volume":"39","author":"Dwight","year":"1998","journal-title":"Psychosomatics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"152060","DOI":"10.1016\/j.semarthrit.2022.152060","article-title":"The economic burden of fibromyalgia: a systematic literature review","volume":"56","author":"D\u2019Onghia","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e2212939","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and US food and drug administration-approved treatments for fibromyalgia: a systematic review and network meta-analysis","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"B38","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/cns.12314","article-title":"Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up","volume":"20","author":"Fayed","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings","volume":"10","author":"Fillingim","year":"2009","journal-title":"J. Pain"},{"key":"B40","first-page":"1336","article-title":"A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia","volume":"32","author":"Finckh","year":"2005","journal-title":"J. Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"918216","DOI":"10.1155\/2013\/918216","article-title":"Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2012","journal-title":"Pain Res. Manag."},{"key":"B42","first-page":"99","article-title":"Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome","volume":"12","author":"Fossaluzza","year":"1992","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","article-title":"Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis","volume":"13","author":"Gatti","year":"2012","journal-title":"Pain Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1124\/jpet.118.249409","article-title":"NYX-2925 is a novel N-Methyl-d-Aspartate receptor modulator that induces rapid and long-lasting analgesia in rat models of neuropathic pain","volume":"366","author":"Ghoreishi-Haack","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.55563\/clinexprheumatol\/257e99","article-title":"Fibromyalgia: one year in review 2023","volume":"41","author":"Giorgi","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0304-3959(99)00308-5","article-title":"Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients","volume":"85","author":"Graven-Nielsen","year":"2000","journal-title":"Pain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"25532","DOI":"10.52965\/001c.25532","article-title":"Milnacipran for the treatment of fibromyalgia","volume":"9","author":"Gupta","year":"2021","journal-title":"Health Psychol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"10375","DOI":"10.26355\/eurrev_202311_34311","article-title":"Ferric carboxymaltose therapy reduces pain and improves the quality of life in female patients with fibromyalgia","volume":"27","author":"Hamarat","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejpain.2009.01.006","article-title":"Guidelines on the management of fibromyalgia syndrome \u2013 a systematic review","volume":"14","author":"H\u00e4user","year":"2010","journal-title":"Eur. J. Pain"},{"key":"B50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/rheumatology\/keq354","article-title":"Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"50","author":"H\u00e4user","year":"2011","journal-title":"Rheumatology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"CD010292","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Db Syst. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S2215-0366(20)30074-2","article-title":"Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis","volume":"7","author":"Hindley","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/cts.12584","article-title":"NYX-2925, a novel N-methyl-D-aspartate receptor modulator: a first-in-human, randomized, double-blind study of safety and pharmacokinetics in adults","volume":"12","author":"Houck","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"593842","DOI":"10.3389\/fpsyt.2021.593842","article-title":"The effects of low dose naltrexone on opioid induced hyperalgesia and fibromyalgia","volume":"12","author":"Jackson","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1533-2500.2011.00453.x","article-title":"Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care","volume":"11","author":"Kleinman","year":"2011","journal-title":"Pain Pract."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/acr.25142","article-title":"Efficacy and safety of sublingual cyclobenzaprine for the treatment of fibromyalgia: results from a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Lederman","year":"2023","journal-title":"Arthritis Care Res. Hob."},{"key":"B57","doi-asserted-by":"publisher","first-page":"bqab109","DOI":"10.1210\/endocr\/bqab109","article-title":"Sensory neurons, neuroimmunity, and pain modulation by sex hormones","volume":"162","author":"Lenert","year":"2021","journal-title":"Endocrinology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"105487","DOI":"10.1016\/j.jpain.2025.105487","article-title":"Comparative efficacy of ba-duan-jin and pregabalin in the treatment of fibromyalgia: an RCT with an exploratory analysis based on fMRI","volume":"34","author":"Li","year":"2025","journal-title":"J. Pain"},{"key":"B59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/00207454.2019.1664510","article-title":"Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis","volume":"130","author":"Lian","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.18553\/jmcp.2016.22.3.263","article-title":"Treatment patterns associated with ACR-Recommended medications in the management of fibromyalgia in the United States","volume":"22","author":"Liu","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1097\/PR9.0000000000001229","article-title":"Gender differences in clinical presentations and sensory profiles in patients with fibromyalgia: implications of peripheral and central mechanisms","volume":"10","author":"Liu","year":"2025","journal-title":"PAIN Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"CD007115","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"2014","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1871527311312010009","article-title":"Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial\/microglial phenotypical changes in mice","volume":"12","author":"Luongo","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B64","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series","volume":"3","author":"Mazza","year":"2021","journal-title":"J. Cannabis Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00296-022-05135-y","article-title":"Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: Real-life data from a retrospective cohort","volume":"42","author":"Mehta","year":"2022","journal-title":"Rheumatol. Int."},{"key":"B67","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1038\/s41598-022-16146-x","article-title":"Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis","volume":"12","author":"Migliorini","year":"2022","journal-title":"Sci. Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13018-023-03995-z","article-title":"Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis","volume":"18","author":"Migliorini","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/j.pain.0000000000000622","article-title":"Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan","volume":"157","author":"Miki","year":"2016","journal-title":"Pain"},{"key":"B70","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/PSY.0b013e31825b9855","article-title":"The effect of duloxetine treatment on cognition in patients with fibromyalgia","volume":"74","author":"Mohs","year":"2012","journal-title":"Psychosom. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.3899\/jrheum.110194","article-title":"Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study","volume":"38","author":"Moldofsky","year":"2011","journal-title":"J. Rheumatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"CD011824","DOI":"10.1002\/14651858.CD011824","article-title":"Amitriptyline for fibromyalgia in adults","volume":"5","author":"Moore","year":"2019","journal-title":"Cochrane Db Syst. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/OARRR.S358255","article-title":"Evaluating gender differences in egyptian fibromyalgia patients using the 1990, 2011, and 2016 ACR criteria","volume":"14","author":"Moshrif","year":"2022","journal-title":"Open Access Rheumatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"172750","DOI":"10.1016\/j.ejphar.2019.172750","article-title":"A novel GABAB receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia","volume":"865","author":"Murai","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s43440-020-00103-4","article-title":"Anxiolytic-like effects of mirogabalin, a novel ligand for \u03b12\u03b4 ligand of voltage-gated calcium channels, in rats repeatedly injected with acidic saline intramuscularly, as an experimental model of fibromyalgia","volume":"72","author":"Murasawa","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"111647","DOI":"10.1016\/j.biopha.2021.111647","article-title":"Mirogabalin, a novel ligand for \u03b12\u03b4 subunit of voltage-gated calcium channels, improves cognitive impairments in repeated intramuscular acidic saline injection model rats, an experimental model of fibromyalgia","volume":"139","author":"Murasawa","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/FBP.0000000000000488","article-title":"A single administration of Neurotropin reduced the elongated immobility time in the forced swimming test of rats exposed to repeated cold stress","volume":"30","author":"Nasu","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.120.265942","article-title":"Mirtazapine, an \u03b12 antagonist-type antidepressant, reverses pain and lack of morphine analgesia in fibromyalgia-like mouse models","volume":"375","author":"Neyama","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/papr.12319","article-title":"The effect of a novel form of extended-release Gabapentin on pain and sleep in fibromyalgia subjects: an open-label pilot study","volume":"16","author":"North","year":"2016","journal-title":"Pain Pract."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.pain.2014.09.004","article-title":"Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up","volume":"155","author":"Olivan-Bl\u00e1zquez","year":"2014","journal-title":"PAIN"},{"key":"B81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ejcn.2009.149","article-title":"Association between serum ferritin level and fibromyalgia syndrome","volume":"64","author":"Ortancil","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"B82","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.ijchp.2020.08.001","article-title":"Differential efficacy between cognitive-behavioral therapy and mindfulness-based therapies for chronic pain: systematic review","volume":"21","author":"Pardos-Gasc\u00f3n","year":"2021","journal-title":"Int. J. Clin. Health Psychol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biomedicines5020016","article-title":"Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia","volume":"5","author":"Parkitny","year":"2017","journal-title":"Biomedicines"},{"key":"B84","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.amjmed.2006.06.006","article-title":"A randomized, controlled, trial of controlled release paroxetine in fibromyalgia","volume":"120","author":"Patkar","year":"2007","journal-title":"Am. J. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3899\/jrheum.110569","article-title":"An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia","volume":"38","author":"Pauer","year":"2011","journal-title":"J. Rheumatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"554899","DOI":"10.3389\/fpsyt.2020.554899","article-title":"A systematic review of efficacy, safety, and tolerability of duloxetine","volume":"11","author":"Rodrigues-Amorim","year":"2020","journal-title":"Front. Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1089\/107999099313523","article-title":"Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha","volume":"19","author":"Russell","year":"","journal-title":"J. Interferon Cytokine Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1089\/107999099313514","article-title":"Reduction of morning stiffness and improvement in physical function in fibromyalgia syndrome patients treated sublingually with low doses of human interferon-alpha","volume":"19","author":"Russell","year":"","journal-title":"J. Interferon Cytokine Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/art.24142","article-title":"Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double\u2010blind, placebo\u2010controlled, multicenter clinical trial","volume":"60","author":"Russell","year":"2009","journal-title":"Arthritis and Rheumatism."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.pain.2010.12.022","article-title":"Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study","volume":"152","author":"Russell","year":"2011","journal-title":"Pain"},{"key":"B91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/030006059302100202","article-title":"A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome","volume":"21","author":"Santandrea","year":"1993","journal-title":"J. Int. Med. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00210-019-01628-z","article-title":"Analgesic effects of mirogabalin, a novel ligand for \u03b12\u03b4 subunit of voltage-gated calcium channels, in experimental animal models of fibromyalgia","volume":"392","author":"Saeki","year":"2019","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.55563\/clinexprheumatol\/pmdzcq","article-title":"Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study","volume":"41","author":"Salaffi","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1345\/aph.1D112","article-title":"Venlafaxine treatment of fibromyalgia","volume":"37","author":"Sayar","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/papr.12302","article-title":"The comparative burden of chronic widespread pain and fibromyalgia in the United States","volume":"16","author":"Schaefer","year":"2016","journal-title":"Pain Pract."},{"key":"B97","first-page":"1070","article-title":"The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia","volume":"30","author":"Scharf","year":"2003","journal-title":"J. Rheumatol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1185\/030079906x112651","article-title":"Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief","volume":"22","author":"Schley","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"B99","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1871527318666190227205359","article-title":"Ultramicronized palmitoylethanolamide (um-PEA) as Add-on treatment in fibromyalgia syndrome (FMS): retrospective observational study on 407 patients","volume":"18","author":"Schweiger","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/BMR-2004-17204","article-title":"A study to compare the therapeutic efficacy of aerobic exercise and paroxetine in fibromyalgia syndrome","volume":"17","author":"Sencan","year":"2004","journal-title":"J. Back Musculoskelet. Rehabil."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/annrheumdis-2011-200418","article-title":"Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial","volume":"71","author":"Spaeth","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1186\/ar4375","article-title":"Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia","volume":"15","author":"Spaeth","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1176\/appi.psy.41.4.371","article-title":"Fibromyalgia symptoms relieved by flupirtine: an open-label case series","volume":"41","author":"Stoll","year":"2000","journal-title":"Psychosomatics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JPR.S274563","article-title":"A KCa3.1 channel opener, ASP0819, modulates nociceptive signal processing from peripheral nerves in fibromyalgia-like pain in rats","volume":"14","author":"Takeshita","year":"2021","journal-title":"J. Pain Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (Alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"CD010782","DOI":"10.1002\/14651858.CD010782.pub2","article-title":"WITHDRAWN: anticonvulsants for fibromyalgia","volume":"10","author":"\u00dc\u00e7eyler","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B108","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk","year":"2019","journal-title":"Pain"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jcpt.12216","article-title":"A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia","volume":"40","author":"VanderWeide","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.2337\/dc14-1044","article-title":"Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study","volume":"37","author":"Vinik","year":"2014","journal-title":"Diabetes Care"},{"key":"B111","doi-asserted-by":"publisher","first-page":"827290","DOI":"10.1155\/2009\/827290","article-title":"Tetrahydrocannabinol (delta 9-THC) treatment in chronic central neuropathic pain and fibromyalgia patients: results of a multicenter survey","volume":"2009","author":"Weber","year":"2009","journal-title":"Anesthesiol. Res. Pract."},{"key":"B112","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2015.05.016","article-title":"Treatment of pain in fibromyalgia patients with testosterone gel: pharmacokinetics and clinical response","volume":"27","author":"White","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"key":"B114","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1345\/aph.1R725","article-title":"Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study","volume":"47","author":"Yeephu","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","article-title":"Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study","volume":"10","author":"Younger","year":"2009","journal-title":"Pain Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"e5180","DOI":"10.1371\/journal.pone.0005180","article-title":"Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology","volume":"4","author":"Younger","year":"2009","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.37734","article-title":"Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","volume":"65","author":"Younger","year":"2013","journal-title":"Arthritis Rheum."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1651181\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:18:30Z","timestamp":1760069910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1651181\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":117,"alternative-id":["10.3389\/fphar.2025.1651181"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1651181","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"article-number":"1651181"}}